Feed supplements comprising a fish-derived hydrolysate peptide composition and zinc oxide and animal food product containing the feed supplement are provided herein. Also provided are methods of feeding swine by supplying the feed supplement or a swine food product made therefrom to swine. The swine may be nursery piglets and the feed may be supplied at weaning and lead to better growth, better food intake and increased feed conversion. The swine may also be gestating or nursing sows.

A trace element solution comprises at least the following metals: zinc; manganese; selenium; and copper; and which comprises a concentration of the metals of at least 90 mg/ml. The solution may comprise the following concentrations: at least 60 mg/ml zinc; at least 10 mg/ml manganese; at least 5 mg/ml selenium; and at least 15 mg/ml copper. The solution may comprise chromium, iodine and chromium.

A trace element solution comprises at least the following metals: zinc; manganese; selenium; and copper; and which comprises a concentration of the metals of at least 90 mg/ml. The solution may comprise the following concentrations: at least 60 mg/ml zinc; at least 10 mg/ml manganese; at least 5 mg/ml selenium; and at least 15 mg/ml copper. The solution may comprise chromium, iodine and chromium.

Provided is pet food which has a moisture content of 15% to 30% by mass and a saccharide content of 5% by mass or less in terms of solid content and contains 0.001% by mass or greater of free cysteine.

The present invention relates to an additive to poultry feed including nitrates, nitrites or their mixtures that reduces the incidence of pectoral myopathy in poultry, for example, wooden breast myopathy in broiler chickens. In one aspect, a method for reducing the incidence of pectoral myopathy in poultry is disclosed. The method includes feeding poultry a feed having one or more nitrates, one or more nitrites, or a mixture thereof, wherein the amount of nitrates and/or nitrites in the feed is 3 g to 2,500 g per ton of feed.

Disclosed herein are compositions and methods for modulating a macrolide antimicrobial, modulating an immune function, increasing the effectiveness of an antibiotic, and/or increasing the number and effectiveness of alveolar macrophages in treating a vertebrate animal. The method comprises feeding to the animal a feed composition comprising (1, 3), (1, 6), beta-glucans and optionally mannans to increase the number of alveolar macrophage cells, and administering a macrolide antibiotic to the animal.

A pet food supplement is provided. The pet food supplement includes the following therapeutic components: curcumin bioavailability, joint preserving and building, fat soluble vitamin absorption, immune system preserving and building, and cancer prevention. One embodiment of the pet food supplement includes turmeric, BIOPERINE, glucosamine, Chondroitin Sulfate, Methylsulfonylmethane, Sodium Hyaluronate, Vitamin B1, Vitamin C, Vitamin E, Manganese, Zinc, kelp, grape seed extract, Vitamin B6, Vitamin B9, Vitamin B12, the Vitamin C, Vitamin A, Vitamin D, Vitamin K, Omega-3, and Omega-6. Each of these ingredients is premixed and orally delivered to the pet in the form of a powder, paste or segment having a size and weight or other dosage measuring feature adjusted in accordance with a weight of the pet.

The present invention provides domestic animal water modifying compositions, domestic animal water modifying compositions with copper, domestic animal water modifying compositions with silver and domestic animal feed modifying compositions. Such compositions are provided to domestic animals to provide, for example, improved weight gain, decreased mortality, improved feed conversion rations, improved overall health and reductions in grow-out periods for domestic animals to which such compositions are administered.

The present invention relates to a method for treating autism spectrum disorders (ASD) or ASD-like symptom, particularly by administering a zinc ion source and/or a serine component e.g. D-serine or its precursor/analogue, optionally in combination with a mixture of branched-chain amino acids (BCAAs). The present invention also relates to a combination, kit or composition for performing the method for treatment as described herein. Further described is use of a zinc ion source and/or a serine component and optional BCAAs for manufacturing a medicament for treating a symptom or disease characteristics associated with ASD or ASD-associated disorder or as a food supplement for ameliorating relevant symptoms in a subject in need thereof. The present invention further provides an animal model for autistic spectrum disorder (ASD) with deficient CTTNBP2 gene, and a method for identifying an ingredient effective in the treatment of ASD by using such animal model.

Embodiments of the invention relate to a method of making a mineral product. The method includes contacting a carboxylic acid and an inorganic mineral compound sufficient to form a solution, reacting the solution over a period of time sufficient to provide a mineral chelated compound, transferring the mineral chelated compound to one or more molds prior to the compound substantially solidifying and reducing the size of the mineral chelated compound sufficient to provide a rapidly soluble mineral chelated product.